The ISPOR Short Course Program Is Virtual and In-Person for 2022

The renowned ISPOR Short Course Program is being offered virtually and in-person at ISPOR 2022 and ISPOR Europe 2022. The program is designed to enhance knowledge and techniques in core health economics and outcomes research (HEOR) topics as well as emerging trends in the field. Taught by expert faculty, short courses topics are offered across 7 topical tracks and range in skill level from introductory to experienced.

Check Back for More Virtual Short Courses for 2022

Expand your HEOR knowledge from the safety and comfort of your home or office. ISPOR's expert short course faculty are presenting the same curriculum that has historically been offered at ISPOR in-person events through an interactive virtual experience. The courses are not recorded so attendance in the live-broadcast is important. These hand-picked virtual courses, along with their electronic course books, provide a solid foundation in essential methodologies and emerging issues.


2-3 February 2022: Understanding Survival Modeling with Application to HTA (Virtual)

LEVEL: Intermediate
TRACK:
Methodological & Statistical Research
LENGTH:
4 Hours | Course runs 2 consecutive days, 2 hours each day

Wednesday, 2 February 2022 | Course runs 2 consecutive days, 2 hours per day
9:00AM-11:00AM Eastern Standard Time (EST)
14:00PM-16:00PM Coordinated Universal Time (UTC) 
15:00PM-17:00PM (CET) Central European Time 

Thursday, 3 February 2022 | Course runs 2 consecutive days, 2 hours per day
9:00AM-11:00AM Eastern Standard Time (EST)
14:00PM-16:00PM Coordinated Universal Time (UTC)
15:00PM-17:00PM (CET) Central European Time

Class Time: 4 Hours | Course runs 2 consecutive days, 2 hours each day

Click for time zone conversion

DESCRIPTION
Time-to-event (survival) analysis is an important element in many economic analyses of healthcare technologies. This is particularly true in oncology given the requirement to estimate lifetime costs and outcomes (ie, extrapolate) beyond the follow-up typically observed in clinical trials. Cost-effectiveness estimates can be sensitive to the methods applied in modeling survival data. Recommendations for selecting a parametric survival model have been recently published, following a review of extrapolation modelling in National Institute for Health and Care Excellence (NICE) technology appraisals. The purpose of this course is to provide participants with an understanding of the fundamentals of survival analysis and key issues to be considered when comparing alternative survival models for inclusion in cost-effectiveness analysis. This will include an understanding of differences between partitioned survival and Markov-based approaches.<
FACULTY MEMBERS

Chris Parker, MSc
Director, Worldwide HEOR Markets RoW, CAR T and Lymphoma
Bristol Myers Squibb
Uxbridge, UK

Andrew Briggs, DPhil
Professor of Health Economics
London School of Hygiene & Tropical Medicine
London, UK

James Lewsey, PhD
Reader, Medical Statistics and Director for HTA
Health Economics and Technology Assessment
Institute of Health & Wellbeing
University of Glasgow
Glasgow, UK

 


14-17 February 2022: Introduction to Health Economics and Outcomes Research (Virtual)

LEVEL: Introductory
TRACK: Economic Evaluation
LENGTH: 8 Hours | Course runs 4 consecutive days, 2 hours each day

Monday, 14 February 2022 | Course runs 4 consecutive days, 2 hours per day
10:00AM–12:00PM Eastern Standard Time (EST)
15:00PM–17:00PM Coordinated Universal Time (UTC)
16:00PM–18:00PM Central European Time (CET)

Tuesday, 15 February 2022 | Course runs 4 consecutive days, 2 hours per day
10:00AM–12:00PM Eastern Standard Time (EST)
15:00PM–17:00PM Coordinated Universal Time (UTC)
16:00PM–18:00PM Central European Time (CET)

Wednesday, 16 February 2022 | Course runs 4 consecutive days, 2 hours per day
10:00AM–12:00PM Eastern Standard Time (EST)
15:00PM–17:00PM Coordinated Universal Time (UTC)
16:00PM–18:00PM Central European Time (CET)

Thursday, 17 February 2022 | Course runs 4 consecutive days, 2 hours per day
10:00AM–12:00PM Eastern Standard Time (EST)
15:00PM–17:00PM Coordinated Universal Time (UTC)
16:00PM–18:00PM Central European Time (CET)

Class Time: 8 Hours | Course runs 4 consecutive days, 2 hours each day

Click for time zone conversion

DESCRIPTION
This course is designed to teach clinicians and new researchers how to incorporate health economics into study design and data analysis. Participants will first review the basic principles and concepts of health economic evaluations, then discuss how to collect and calculate the costs of different alternatives, determine the economic impact of clinical outcomes, and how to identify, track, and assign costs to different types of healthcare resources used. Different health economic models and techniques will be demonstrated including cost-minimization, cost-effectiveness, cost-benefit, cost-utility, and budget impact analysis. Decision analysis, sensitivity analysis, and discounting will all be demonstrated and practiced. This course is suitable for those with little or no experience with health economics.
FACULTY MEMBERS
Lorne E. Basskin, PharmD
Adjunct Professor 
School of Pharmacy
University of Charleston
Charleston, WV, USA


1-2 March 2022: Introduction to Health Technology Assessment (Virtual)

LEVEL: Introductory
TRACK: Health Technology Assessment
LENGTH: 4 Hours | Course runs 2 consecutive days, 2 hours each day

Tuesday, 1 March 2022 | Course runs 2 consecutive days, 2 hours per day
 9:00AM–11:00AM Eastern Standard Time (EST)
14:00PM–16:00PM Coordinated Universal Time (UTC)
15:00PM–17:00PM Central European Time (CET)

Wednesday, 2 March 2022 | Course runs 2 consecutive days, 2 hours per day
 9:00AM–11:00AM Eastern Standard Time (EST)
14:00PM–16:00PM Coordinated Universal Time (UTC)
15:00PM–17:00PM Central European Time (CET)

Class Time: 4 Hours | Course runs 2 consecutive days, 2 hours each day

Click for time zone conversion

DESCRIPTION
This introductory course is designed to teach academic researchers, health policy decision makers, manufacturers, and clinicians about the key elements, methods, and language of health technology assessment (HTA). The course provides an overview of basic HTA principles including benefit assessment (biostatistics, clinical epidemiology, patient-relevant outcomes, risk-benefit assessment), economic evaluation (costing, cost-effectiveness analysis, pharmacoeconomic modeling, budget impact analysis, resource allocation), and ELSI (ethical, legal, and social implications). Using real world examples covering both drugs and devices, the course will review the practical steps involved in developing and using HTA reports in different countries and health care systems. Group discussion will focus on the perspectives of different stakeholders and the implementation of HTA in health care decision making. This course is suitable for those with little or no experience with HTA.
FACULTY MEMBERS
Uwe Siebert, MD, MPH, MSc, ScD
Professor & Chair
UMIT - University for Health Sciences
Medical Informatics and Technology
Innsbruck, Austria and
Harvard Chan School of Public Health
Harvard University
Boston, MA, USA

Petra Schnell-Inderst, MPH, PhD, Dipl. Biol
Senior Scientist
UMIT - University for Health Sciences
Medical Informatics and Technology
Innsbruck, Austria

Registration Coming Soon!


22-23 March 2022: US Payers–Understanding the Healthcare SystemTM (Virtual)

LEVEL: Introductory
TRACK: Health Policy & Regulatory
LENGTH: 4 Hours | Course runs 2 consecutive days, 2 hours each day

Tuesday, 22 March 2022 | Course runs 2 consecutive days, 2 hours per day
10:00AM–12:00PM Eastern Daylight Time (EDT)
14:00PM–16:00PM Coordinated Universal Time (UTC)
15:00PM–17:00PM Central European Time (CET)

Wednesday, 23 March 2022 | Course runs 2 consecutive days, 2 hours per day
10:00AM–12:00PM Eastern Daylight Time (EDT)
14:00PM–16:00PM Coordinated Universal Time (UTC)
15:00PM–17:00PM Central European Time (CET)

Class Time: 4 Hours | Course runs 2 consecutive days, 2 hours each day

Click for time zone conversion

DESCRIPTION
The US healthcare system is a hybrid system that provides access to care via various channels and means. It can be categorized as: governmental systems (Medicare, Medicaid, Veterans Health Administration, and Department of Defense, etc), private markets (privately sponsored regional and national health plans), and providers assuming responsibility for access and coverage via mechanisms such as Provider Networks, Integrated Delivery Networks (IDNs), Accountable Care Organizations (ACOs), etc. These elements are quite heterogeneous and characterized by different coverage and access mechanisms. This introductory course will cover the roots of the current US system, its evolutionary process, and the consequent independence of these different parts of the system. The focus will be on value and affordability as defined by cost, access, and quality. While all hold value and affordability as important goals, the different stakeholders take various perspectives and define these goals differently. This results in different objectives, incentives, and principles under which they operate. The intent of this course is to better understand characteristics of the different parts of the US healthcare system and the role of various decision makers within it. The course will cover their structure, scope, processes, and perspectives as well as their approach to balancing access, costs and quality. The course will also cover how industry and others produce evidence to support access and reimbursement decisions and how the evidence is used by decision makers. This session will facilitate the increased level of understanding of these disparate systems and emphasize the need to effectively communicate evidence to various access decision makers to support and enhance evidence driven decision making on value and affordability. This course is designed for those having limited experience in understanding the structure of the US healthcare system, including its various subsystems and how they operate. The course will focus on how these entities differ in perspectives, coverage mechanisms, and the means and evidence they use to define and achieve both value (access and quality) and affordability.
FACULTY MEMBERS
Finn Børlum Kristensen, MD, PhD
Professor
Department of Public Health
Research Unit of User Perspectives
Faculty of Health Sciences
University of Southern Denmark
Hillerød, Denmark

James F. Murray, PhD
Chief Scientific Officer
Decision Alternatives Collaborative L.L.C.
Carmel, IN, USA

Laura T. Pizzi, RPh, PharmD, MPH
Associate Chief Science Officer
ISPOR
Lawrenceville, NJ, USA

Jessica Daw, MBA, PharmD
Vice President, Pharmacy
Sentara Health Plans
Virginia Beach, VA, USA

Registration Coming Soon!


22-23 June 2022: An Introduction to Patient Engagement in

Medical-Product Research (Virtual)

LEVEL: Introductory
TRACK: Patient Centered Research
LENGTH: 4 Hours | Course runs 2 consecutive days, 2 hours each day

Wednesday, 22 June 2022 | Course runs 2 consecutive days, 2 hours per day
10:00AM–12:00PM Eastern Daylight Time (EDT)
14:00PM–16:00PM Coordinated Universal Time (UTC)
16:00PM–18:00PM Central European Time (CET)

Thursday, 23 June 2022 | Course runs 2 consecutive days, 2 hours per day
10:00AM–12:00PM Eastern Daylight Time (EDT)
14:00PM–16:00PM Coordinated Universal Time (UTC)
16:00PM–18:00PM Central European Time (CET)

Class Time: 4 Hours | Course runs 2 consecutive days, 2 hours each day

Click for time zone conversion


DESCRIPTION
Over the past decade, the role of patients as partners in medical-product development has increased. Add to that the development of Food and Drug Administration’s regulatory guidance for Patient-Focused Drug Development and the EMA’s patient input system, there is increasing an industry-wide focus on how to “collect information on the patient experience that is representative of the intended population to inform the development and evaluation of medical products throughout the medical product lifecycle.” Health economics and outcomes research (HEOR) stakeholders, including ISPOR members, are actively seeking to meaningfully partner with patients to incorporate patient-provided information and input into their research. 

This half-day course is designed to provide participants with an introduction to patient engagement (PE) in medical-product research through defining PE and providing its historical context and significance throughout ISPOR’s HEOR taxonomy. This course will also equip attendees with tools to plan and implement meaningful PE activities in their respective areas of research expertise (eg, clinical development, epidemiology, health economics, real-world evidence, etc). The course will differentiate the skills needed for PE and who should be engaging versus methods for using patient experience data in research. There will be a session dedicated to addressing challenges in implementing PE in a clinical research environment. Real-world examples of patient-researcher partnerships will be presented to discuss best practices and demonstrate practical solutions to some of these challenges. One of the course’s strengths is that attendees will have the opportunity to interact with stakeholders who represent a variety of perspectives. Interaction with stakeholders and other attendees may also result in unique opportunities for further collaboration in PE medical-product research.
FACULTY MEMBERS
Elisabeth Oehrlein, PhD, MS
Assistant Vice President, Research and Programs
National Health Council
Washington, DC, USA

Robert McBurney, PhD
Chief Research Officer
Accelerated Cure Project for MS
Waltham, MA, USA

M. Suz Schrandt, JD
Founder & CEO
ExPPect
Arlington, VA, USA

Allison Martin Nguyen, MS
Senior Principal Scientist
Merck & Co
West Point, PA, USA

Registration Coming Soon!


Registration Rates for ISPOR Short Courses

8 Hour | 2 Day or 4 Day  Short CourseNon-member
Rate
Member Rate
Standard $680$510
Clinical Practitioners$510$385
Full-Time Government and Academia$475$360
Patient Representative$340$225
Full-Time Students (must provide current enrollment docs)$200$160
  
4 Hour | 1 or 2 Day Short CourseNon-memberMember Rate
Standard$340$255
Clinical Practitioners$255$190
Full-Time Government and Academia
$240$180
Patient Representative$170$130
Full-Time Students (must provide current enrollment docs)$100$80

The cancellation date for short courses is 2 weeks before the course. All cancellation requests must be made in writing and emailed to ISPOR Registration. A $50.00 cancellation fee applies. After the 2 week period no refund can be provided.

Additional Short Course Program Details

Short Course Tracks

ISPOR short courses are offered across the following topical tracks:

  • Economic Evaluation
  • Methodological & Statistical Research
  • Study Approaches
  • Real World Data & Information Systems
  • Patient-Centered Research
  • Health Policy & Regulatory
  • Health Technology Assessment

Short Course Core Curriculum

ISPOR short course core curriculum is defined as essential curriculum for professional success in the HEOR field; courses/topic areas that are offered at all conferences and the building blocks of a fundamental curriculum that can be applied to future educational programs/offerings.

  • Economic Evaluation
    • Introduction to Health Economics and Outcomes Research
    • Statistical Methods for Health Economics and Outcomes Research
    • Budget Impact Analysis I – A 6-Step Approach
  • Methodology & Statistical Methods
    • Introduction to Modeling Methods
  • Study Approaches
    • Introduction to the Design & Database Analysis of Observational Studies of Treatment Effects
    • Meta-analysis & Systematic Literature Review
    • Network Meta-Analysis
  • Patient-Centered Research
    • Introduction to Patient-Reported Outcomes
    • Utility Measures
  • Health Policy & Regulatory
    • Elements of Pharmaceutical/Biotech Pricing
    • Risk-Sharing/Performance-Based Arrangements for Drugs and Other Medical Products
    • Global Payers/US Payers
  • Health Technology Assessment
    • Introduction to Health Technology Assessment

 

Need More Information or Have Questions?

Contact us for more information on ISPOR education and training.

Contact Us

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×